Print

BIOTRONIK Receives FDA Approval for Expansion of the Premium Evia Pacemaker Portfolio  
4/27/2011 8:30:36 AM

LAKE OSWEGO, Ore. & BERLIN--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced FDA approval of the new Estella and Effecta pacemakers, as well as advanced new features and technologies for the Evia pacemaker family.
//-->